Norofert Past Earnings Performance

Past criteria checks 0/6

Norofert's earnings have been declining at an average annual rate of -22.9%, while the Chemicals industry saw earnings growing at 7.3% annually. Revenues have been growing at an average rate of 1.3% per year.

Key information

-22.9%

Earnings growth rate

-25.4%

EPS growth rate

Chemicals Industry Growth39.7%
Revenue growth rate1.3%
Return on equity-22.3%
Net Margin-11.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Is Norofert (BVB:NRF) Using Too Much Debt?

Sep 19
Is Norofert (BVB:NRF) Using Too Much Debt?

Revenue & Expenses Breakdown

How Norofert makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BVB:NRF Revenue, expenses and earnings (RON Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2445-560
31 Mar 2442-670
31 Dec 2344-470
30 Sep 2353460
30 Jun 2365850
31 Mar 23711050
31 Dec 22731150
30 Sep 22761060
30 Jun 2264850
31 Mar 22641050
31 Dec 2153750
30 Sep 2138340
30 Jun 2131540
31 Mar 2123140
31 Dec 2025440
30 Sep 2030940
30 Jun 2027840
31 Mar 2021630
31 Dec 1915520
31 Dec 1810410

Quality Earnings: NRF is currently unprofitable.

Growing Profit Margin: NRF is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NRF is unprofitable, and losses have increased over the past 5 years at a rate of 22.9% per year.

Accelerating Growth: Unable to compare NRF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NRF is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.7%).


Return on Equity

High ROE: NRF has a negative Return on Equity (-22.34%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies